chronic kidney disease
Conditions
Interventions
CKD stage 1:none
CKD stage 2:none
CKD stage 3:none
CKD stage 4:none
CKD stage 5:none
Sponsors
Tibet Autonomous Region People’s Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) signing the Informed Consent voluntarily; 2) aged 18 to 80 years; 3) patients with chronic kidney disease on stage 1-5 in stable condition; 4) haven't use rhEPO recently (6 days for i.h., 3 days for i.v.).
Exclusion criteria
Exclusion criteria: 1) living in Tibetan plateau less than 6 months; 2) acute kidney injury; 3) polycystic kidney disease; 4) acute infection within 1 month; 5) acute bleeding or receive blood transfusion within 1 month; 6) acute myocardial infarction or heart failure (NYHA IV) or cerebral stroke within 3 months; 7) severe pulmonary disease; 8) uncontrolled malignant tumor; 9) active viral hepatitis; 10) rheumatic disease on active stage; 11) in Pregnancy or Lactation; 12) is participating in other clinical trials that may interfere the result of this research; 13) other conditions that researchers consider may affect the result.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| erythropoietin; | — |
Countries
China
Contacts
Public ContactLei zhang
Tibet Autonomous Region People’s Hospital
Outcome results
None listed